Clopidogrel Teva Pharma (previously Clopidogrel HCS) Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

clopidogrel teva pharma (previously clopidogrel hcs)

teva b.v.  - clopidogrel (as hydrochloride) - myocardial infarction; peripheral vascular diseases; stroke - antithrombotic agents - clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.adult patients suffering from acute coronary syndrome:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa).st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.prevention of atherothrombotic and thromboembolic events in atrial fibrillation in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke.

Telmisartan Teva Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

telmisartan teva

teva b.v. - telmisartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension in adults

TEVA-ATENOLOL TABLET Canada - Tiếng Anh - Health Canada

teva-atenolol tablet

teva canada limited - atenolol - tablet - 50mg - atenolol 50mg - beta-adrenergic blocking agents

TEVA-ATENOLOL TABLET Canada - Tiếng Anh - Health Canada

teva-atenolol tablet

teva canada limited - atenolol - tablet - 100mg - atenolol 100mg - beta-adrenergic blocking agents